China Resources Pharmaceutical Group Limited (3320)

Overview

China Resources Pharmaceutical Group Limited, a significant player in the healthcare and pharmaceutical sectors, incorporates a comprehensive approach to its business by engaging in the research, development, manufacture, distribution, and retail of pharmaceutical and other healthcare products. Primarily operating in Mainland China and Hong Kong, the company functions through four main segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. Originally known as China Resources Medications Group Limited, it rebranded to its current name in December 2011. Established in 2007 and headquartered in Wan Chai, Hong Kong, this subsidiary of CRH (Pharmaceutical) Limited has a broad operational scope, catering to various healthcare needs through its extensive product portfolio and services. It distinguishes itself through a potent mix of manufacturing, comprehensive distribution network, and retail capabilities, all aimed at improving healthcare accessibility and efficiency.

Products and Services

The company's offerings span across a wide array of healthcare needs, ensuring a comprehensive approach to wellbeing and medical care:

• Chemical Drugs: These encompass a broad range of medication designed to address various health conditions, leveraging chemical science for therapeutic benefits.
• Chinese Medicines: Traditional Chinese medicines are offered, tapping into centuries-old practices and natural remedies for health and wellness.
• Biopharmaceutical Drugs: Focusing on biologically based treatments, these drugs represent the cutting-edge of therapeutic innovation, targeting a wide range of illnesses with precision medicine.
• Nutritional and Healthcare Products: A variety of products aimed at promoting general health, addressing nutritional deficiencies, and supporting disease prevention efforts.
• Pharmaceutical Manufacturing: The segment involves the production of a diverse drug portfolio, ensuring high-quality manufacturing practices and compliance with global standards.
• Pharmaceutical Distribution: This includes warehousing, logistics, and other pharmaceutical supply chain solutions, aimed at efficiently distributing products to hospitals, distributors, and pharmacies.
• Pharmaceutical Retail: With retail pharmacies operating under the CR Care and Teck Soon Hong brands, this segment ensures direct access to medicines and healthcare products for consumers.
• Other Services: In addition to its core offerings, the company engages in property holding activities and provides value-added services related to the pharmaceutical supply chain to enhance the overall efficiency and effectiveness of healthcare product distribution.